BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1340 related articles for article (PubMed ID: 28787537)

  • 21. Pharmacotherapy for hyperuricemia in hypertensive patients.
    Gois PHF; Souza ERM
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008652. PubMed ID: 28406263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure lowering efficacy of renin inhibitors for primary hypertension.
    Musini VM; Lawrence KA; Fortin PM; Bassett K; Wright JM
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007066. PubMed ID: 28379619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of weight-reducing drugs in people with hypertension.
    Siebenhofer A; Winterholer S; Jeitler K; Horvath K; Berghold A; Krenn C; Semlitsch T
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD007654. PubMed ID: 33454957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eplerenone for hypertension.
    Tam TS; Wu MH; Masson SC; Tsang MP; Stabler SN; Kinkade A; Tung A; Tejani AM
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008996. PubMed ID: 28245343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients.
    Stabler SN; Tejani AM; Huynh F; Fowkes C
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD007653. PubMed ID: 22895963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy for hyperuricaemia in hypertensive patients.
    Gois PHF; Souza ERM
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD008652. PubMed ID: 32877573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium supplementation for prevention of primary hypertension.
    Cormick G; Ciapponi A; Cafferata ML; Cormick MS; Belizán JM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD010037. PubMed ID: 35014026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy for hypertension-induced left ventricular hypertrophy.
    Leache L; Gutiérrez-Valencia M; Finizola RM; Infante E; Finizola B; Pardo Pardo J; Flores Y; Granero R; Arai KJ
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012039. PubMed ID: 34628642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-line combination therapy versus first-line monotherapy for primary hypertension.
    Garjón J; Saiz LC; Azparren A; Elizondo JJ; Gaminde I; Ariz MJ; Erviti J
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010316. PubMed ID: 28084624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium supplementation for prevention of primary hypertension.
    Cormick G; Ciapponi A; Cafferata ML; Cormick MS; Belizán JM
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD010037. PubMed ID: 34693985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of weight-reducing diets in people with hypertension.
    Semlitsch T; Krenn C; Jeitler K; Berghold A; Horvath K; Siebenhofer A
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD008274. PubMed ID: 33555049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low dialysate sodium levels for chronic haemodialysis.
    Dunlop JL; Vandal AC; Marshall MR
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011204. PubMed ID: 30646428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course for blood pressure lowering of beta-blockers with partial agonist activity.
    Zhang XY; Soufi S; Dormuth C; Musini VM
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010054. PubMed ID: 32888198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of weight-reducing drugs in people with hypertension.
    Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T
    Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy for hyperuricemia in hypertensive patients.
    Gois PH; Souza ER
    Cochrane Database Syst Rev; 2013 Jan; (1):CD008652. PubMed ID: 23440832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.